{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:50:19Z","timestamp":1781934619937,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Plan Project of Jinan Municipal Health and Family Planning Commission","award":["2018-1-07"],"award-info":[{"award-number":["2018-1-07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The purpose of this study is to compare the difference of clinical efficacy between conventional intraperitoneal chemotherapy and HIPEC, so as to explore the clinical application value and advantages of HIPEC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted on 80 patients with malignant ascites admitted to our hospital from June 2017 to June 2019. The general clinical data and qualitative data of the treatment results of 80 patients with malignant ascites were processed by SPSS19.0 using\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      test, and quantitative data were processed by\n                      <jats:italic>t<\/jats:italic>\n                      test.\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05, statistical data can be considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"order\">\n                        <jats:list-item>\n                          <jats:p>There was no significant change in vital signs and temperature in the observation group during the treatment, and the difference was not statistically significant.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The short-term total effective rate of patients in the observation group was 91.11%, and the short-term total effective rate of the patients in the control group was 40%.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>There was no significant difference in the incidence of adverse reactions between the two groups of patients.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intraperitoneal hyperthermic chemotherapy combined with intravenous chemotherapy can significantly control malignant ascites and has small adverse reactions, which is worthy of clinical promotion and application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-020-01956-y","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T12:03:43Z","timestamp":1595419423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites"],"prefix":"10.1186","volume":"18","author":[{"given":"Jie","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"issue":"3","key":"1956_CR1","first-page":"446","volume":"17","author":"A Kalogeraki","year":"2012","unstructured":"Kalogeraki A, et al. Cytopathologic interpretation of ascites due to malignancy. J buon. 2012;17(3):446\u201351.","journal-title":"J buon"},{"issue":"1","key":"1956_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jso.25453","volume":"120","author":"C Hodge","year":"2019","unstructured":"Hodge C, Badgwell BD. Palliation of malignant ascites. J Surgical Oncol. 2019;120(1):67\u201373.","journal-title":"J Surgical Oncol"},{"issue":"39","key":"1956_CR3","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3748\/wjg.v21.i39.10936","volume":"21","author":"H Maeda","year":"2015","unstructured":"Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol. 2015;21(39):10936\u201347.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1956_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.23736\/S0026-4733.18.07649-6","volume":"74","author":"M Robella","year":"2019","unstructured":"Robella M, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes. Minerva Chir. 2019;74(3):195\u2013202.","journal-title":"Minerva Chir"},{"issue":"7","key":"1956_CR5","first-page":"515","volume":"29","author":"BW Loggie","year":"2015","unstructured":"Loggie BW, Thomas P. Gastrointestinal cancers with peritoneal carcinomatosis: surgery and hyperthermic intraperitoneal chemotherapy. Oncology (Williston Park). 2015;29(7):515\u201321.","journal-title":"Oncology (Williston Park)"},{"key":"1956_CR6","unstructured":"de Bree, E., Optimal drugs for HIPEC in different tumors. J buon, 2015. 20 Suppl 1: p. S40-6."},{"key":"1956_CR7","first-page":"513","volume":"89","author":"A Bartos","year":"2018","unstructured":"Bartos A, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis. Ann Ital Chir. 2018;89:513\u201327.","journal-title":"Ann Ital Chir"},{"issue":"7","key":"1956_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00104-019-0982-5","volume":"90","author":"H Leebmann","year":"2019","unstructured":"Leebmann H, Piso P. Hyperthermic intraperitoneal chemotherapy. Chirurg. 2019;90(7):593\u2013604.","journal-title":"Chirurg"},{"key":"1956_CR9","unstructured":"Binyamin S, et al. Intravenous chemotherapy versus intraperitoneal chemotherapy in advanced ovarian cancer: update on the situation worldwide and in Israel. Harefuah. 2015;154(9) 594-8, 607, 606."},{"issue":"11","key":"1956_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/apt.13172","volume":"41","author":"JB Dever","year":"2015","unstructured":"Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41(11):1116\u201331.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1956_CR11","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00520-017-3802-9","volume":"25","author":"BL Rapoport","year":"2017","unstructured":"Rapoport BL, et al. Supportive care for patients undergoing immunotherapy. Support Care Cancer. 2017;25(10):3017\u201330.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1956_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/0256-4947.55167","volume":"29","author":"MW Saif","year":"2009","unstructured":"Saif MW, Siddiqui IA, Sohail MA. Management of ascites due to gastrointestinal malignancy. Ann Saudi Med. 2009;29(5):369\u201377.","journal-title":"Ann Saudi Med"},{"issue":"5 Suppl","key":"1956_CR13","doi-asserted-by":"publisher","first-page":"D17","DOI":"10.1016\/S0399-8320(04)94983-4","volume":"28","author":"B Denis","year":"2004","unstructured":"Denis B, Elias D. Diagnosis and treatment of peritoneal carcinoma. Gastroenterol Clin Biol. 2004;28(5 Suppl):D17\u201325.","journal-title":"Gastroenterol Clin Biol"},{"issue":"7","key":"1956_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","volume":"61","author":"O Aziz","year":"2018","unstructured":"Aziz O, et al. Predicting survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendix adenocarcinoma. Dis Colon Rectum. 2018;61(7):795\u2013802.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"1956_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12032-016-0810-4","volume":"33","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik J, et al. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors. Med Oncol. 2016;33(8):94.","journal-title":"Med Oncol"},{"issue":"12","key":"1956_CR16","first-page":"V06160454","volume":"179","author":"TH Degett","year":"2017","unstructured":"Degett TH, Pommergaard HC, Gogenur I. Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation. Ugeskr Laeger. 2017;179(12):V06160454.","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"1956_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/107327481602300107","volume":"23","author":"R Rajeev","year":"2016","unstructured":"Rajeev R, Turaga KK. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in the management of peritoneal carcinomatosis. Cancer Control. 2016;23(1):36\u201346.","journal-title":"Cancer Control"},{"issue":"11","key":"1956_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","volume":"44","author":"C Rihuete Caro","year":"2018","unstructured":"Rihuete Caro C, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Eur J Surg Oncol. 2018;44(11):1805\u201310.","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"1956_CR19","first-page":"695","volume":"29","author":"A Oseledchyk","year":"2015","unstructured":"Oseledchyk A, Zivanovic O. Intraoperative hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer. Oncology (Williston Park). 2015;29(9):695\u2013701.","journal-title":"Oncology (Williston Park)"},{"issue":"4","key":"1956_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/bjs.10422","volume":"104","author":"NF Kok","year":"2017","unstructured":"Kok NF, de Hingh IH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin. Br J Surg. 2017;104(4):313\u20135.","journal-title":"Br J Surg"},{"issue":"3","key":"1956_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/02656736.2016.1149233","volume":"32","author":"K Polom","year":"2016","unstructured":"Polom K, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer. Int J Hyperthermia. 2016;32(3):298\u2013310.","journal-title":"Int J Hyperthermia"},{"key":"1956_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2017.08.002","volume":"221","author":"AJ Scholer","year":"2018","unstructured":"Scholer AJ, et al. Abdominal wall reconstruction after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy. J Surg Res. 2018;221:266\u201374.","journal-title":"J Surg Res"},{"issue":"9","key":"1956_CR23","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1245\/s10434-019-07603-5","volume":"26","author":"C Eveno","year":"2019","unstructured":"Eveno C, Voron T, Piessen G. Laparoscopic hyperthermic intraperitoneal chemotherapy for patients with gastric peritoneal metastases: limitations and perspectives. Ann Surg Oncol. 2019;26(9):3009\u201310.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01956-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01956-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:40:16Z","timestamp":1626896416000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01956-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01956-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23958\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23958\/v2","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"15 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was done after an agreement from the local ethics committee (Jinan Central Hospital ethics committee) and with the patients\u2019 informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each participant. Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient\/parent\/guardian\/ relative of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}